Liguori, L.; Polcaro, G.; Nigro, A.; Conti, V.; Sellitto, C.; Perri, F.; Ottaiano, A.; Cascella, M.; Zeppa, P.; Caputo, A.;
et al. Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics 2022, 14, 2442.
https://doi.org/10.3390/pharmaceutics14112442
AMA Style
Liguori L, Polcaro G, Nigro A, Conti V, Sellitto C, Perri F, Ottaiano A, Cascella M, Zeppa P, Caputo A,
et al. Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics. 2022; 14(11):2442.
https://doi.org/10.3390/pharmaceutics14112442
Chicago/Turabian Style
Liguori, Luigi, Giovanna Polcaro, Annunziata Nigro, Valeria Conti, Carmine Sellitto, Francesco Perri, Alessandro Ottaiano, Marco Cascella, Pio Zeppa, Alessandro Caputo,
and et al. 2022. "Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors" Pharmaceutics 14, no. 11: 2442.
https://doi.org/10.3390/pharmaceutics14112442
APA Style
Liguori, L., Polcaro, G., Nigro, A., Conti, V., Sellitto, C., Perri, F., Ottaiano, A., Cascella, M., Zeppa, P., Caputo, A., Pepe, S., & Sabbatino, F.
(2022). Bispecific Antibodies: A Novel Approach for the Treatment of Solid Tumors. Pharmaceutics, 14(11), 2442.
https://doi.org/10.3390/pharmaceutics14112442